LEADING THE CHANGE IN TRANSFORMING HEALTHCARE

Improving Specimen Integrity, Accuracy, and Consistency.  One Test at a Time.

Management Team

Gregory J. Bullington

Co-Founder & CEO

Greg Bullington, co-founder and Chief Executive Officer, has led all commercial aspects of company development since inception including clinical trial design and execution, peer-reviewed publication, product development, manufacturing, commercial launch and overall intellectual property strategy. To date, Greg has raised over $30 million in capital to drive the successful growth and development of the company. Greg has extensive experience in the healthcare industry having led product commercialization and strategy engagements for a wide variety of companies in the biotech (novel immunotherapy), healthcare insurance, wellness and enterprise software sectors. Greg began his career in professional services with the Audit & Assurance

Read More

Richard G. Patton, M.D.

Co-Founder & Medical Director

Dr. Richard Patton, co-founder and Medical Director, is a board-certified pathologist with more than 40 years of active practice experience. Recognizing the patient safety and financial implications of false positive blood cultures, he has long been interested in exploring opportunities to reduce contamination rates. In 2006, Dr. Patton designed a clinical trial to test the effectiveness of Initial Specimen Diversion Technique (ISDT), an innovation that he conceived earlier in his career. The results of the trial were significantly positive and published in the peer-reviewed Journal of Clinical Microbiology. Dr. Patton’s areas of expertise are clinical microbiology, gastrointestinal pathology, and cytopathology.

Read More

Robert E. Gerberich

Chief Commercial Officer

Bob Gerberich, Chief Commercial Officer, is a results-driven global business leader with over 25 years of experience in the surgical and medical device segments of the life sciences market. As a senior sales and marketing executive, he has an exceptional track record of success building new markets and driving rapid commercial growth from product introduction through broad scale adoption. Bob joined Magnolia Medical Technologies as Chief Commercial Officer in April 2017. He is responsible for leading all commercial and customer facing functions of the company. Most recently, Bob served as Vice President of Sales and Marketing and Vice President of

Read More

Matthew B. Stuckert

Vice President of Sales

Matt Stuckert, Vice President of Sales, is a senior sales executive with almost twenty years of successful experience leading high performance sales teams, launching new medical devices, and creating new markets, including: ChloraPrep® skin antiseptics, StatLock® catheter securement devices, and other unique products focused in Infection Prevention, Vascular Access, and Surgery. Matt joined Magnolia Medical Technologies as Vice President of Sales in June 2017, and is responsible for the US Sales organization. Most recently, Matt served as Vice President of Business Development for San Francisco-based startup Applied Silver, leading the market introduction of their innovative silver-ion technology for the antimicrobial

Read More

Brad R. Nelson

Vice President of Marketing

Brad Nelson, Vice President of Marketing, is a senior marketing executive with twenty years of experience in medical device and life science automation. He has a proven track record leading global organizations in the development and commercialization of new technologies focused on improving human health.  Brad joined Magnolia Medical Technologies as Vice President of Marketing in September 2017, and is responsible for the Marketing and Product Management organizations. Most recently, Brad served as Senior Director of Corporate Development and Strategy, and Director of Marketing, for Labcyte Inc. He led the expansion of the company into high growth markets, including genomic

Read More

John M. Havard

Vice President of Product Development

John Havard, Vice President of Product Development, has over 25 years of product development experience, in both managerial and engineering roles, in the medical, life science, and consumer industries. John joined Magnolia in September 2017 to build and lead the engineering/product development team. Most recently, John was the Vice President of Engineering and CTO at Stratos Product Development, a medical and consumer product consultancy in Seattle. Over a ten-year period in this role, he worked with dozens of clients, including Google, Welch Allyn, Microsoft, Abbott Labs and several start-ups, overseeing the technical development and staffing of successful products spanning drug

Read More

Jay J. Schwartz

Vice President of Business Development and Strategy

Jay Schwartz, Vice President of Business Development and Strategy, brings a broad range of strategy and hands-on experience to Magnolia Medical Technologies in his role to help set the strategic and operating direction of the company while also supporting the overall business development effort. Initially working with the company since 2015 as an advisor, Jay joined Magnolia full time in the middle of 2016. Prior to Magnolia Medical, Jay’s healthcare experience includes leading Sales, Account Management, Strategic Partner and Corporate Development efforts for a leading healthcare information technology and content company. In addition, he worked with many healthcare clients across

Read More

Board of Directors

Read More
Garheng Kong, MD, PhD
Founder and Managing Partner - HealthQuest Capital
Read More
Paul M. Meister
President - MacAndrews & Forbes, Inc. Co-founder - Liberty Lane Partners, LLC.
Read More
Gregory J. Bullington
Co-Founder & CEO Magnolia Medical Technologies
Read More
Richard G. Patton, M.D.
Co-Founder & Medical Director Magnolia Medical Technologies
Read More
Josh Baltzell
Venture Partner - Split Rock Partners, Venture Partner - SightLine Partners
Read More
Paul Enever
Managing Director - Canepa Healthcare